Double-blind, placebo-controlled, safety and pharmacology study with 75 mg dosage of GBR 12909 in cocaine experienced African American Volunteers. Particular interest is being given to the hematological safety data.
The purpose of this study is to assess GBR 12909 in cocaine experienced African American Volunteers.